Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **thiol group on a protein** refers specifically to the -SH (sulfhydryl) functional group most commonly found on the amino acid cysteine in proteins[1][3][5]. These groups are highly reactive and play several critical biological roles: acting as nucleophiles in enzymatic catalysis, maintaining protein structure and stability via disulfide bond formation, and participating in redox regulation and cellular signaling via reversible modifications such as oxidation, S-nitrosylation, and glutathionylation[1][2][3][4][5][7][8]. The chemical reactivity of protein thiols renders them targets for both physiological (regulatory) and pathological (toxic) modifications. However, “thiol group on protein” is not a single, specific drug target but a chemical feature present on thousands of different proteins, and it occurs in varied biological contexts. For this reason, while key to many drug mechanisms (e.g., N-acetylcysteine, heavy metal chelation), it is not considered a canonical therapeutic target like a specific receptor or enzyme, and the entry as a stand-alone target is too broad and not specific to an individual gene/protein family[3][5][6][7][8]. Caveat: “Thiol groups on proteins” is a **chemical modification site** and not a classical, gene-encoded drug target. It should not generally be considered a distinct therapeutic target entry but rather a feature or motif, unless discussing broad classes of drugs or toxicants that indiscriminately modify protein thiols.
Drugs targeting protein thiols typically act via covalent modification (e.g., alkylation, oxidation, reduction of the thiol group), disulfide bond formation/disruption, S-nitrosylation (NO binding), S-glutathionylation (glutathione addition/removal), or metal ion chelation/inhibition.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thiol group on protein.